IQVIA

IQVIA Holdings Inc. is a multinational company that provides analytics, technology-enabled solutions, and contract research services to the life sciences industry. It was formed in 2016 through the merger of IMS Health and Quintiles and adopted the IQVIA brand in 2017. The company is headquartered in Durham, North Carolina, and operates in more than 100 countries, employing a global workforce across data science, clinical development, and commercial analytics.

IQVIA offers a range of services including real-world evidence generation, data licensing, clinical trial management, pharmacovigilance, and strategic consulting. It also provides technology platforms that integrate analytics with areas such as patient recruitment, market access, and connected health solutions. A core asset is the company’s extensive healthcare data repository, which comprises prescription and claims data, electronic health records, and patient registries. When combined with advanced analytics and artificial intelligence, these data assets support drug development, regulatory decision-making, and commercial strategy for pharmaceutical and biotechnology clients.

As a publicly traded company, IQVIA is listed on the New York Stock Exchange under the ticker IQV. The firm operates in a competitive landscape with other large contract research organizations and data analytics providers. IQVIA also emphasizes governance and compliance, addressing data privacy, security, and ethical considerations in handling health information across international markets.